http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
St. Jude Medical HeartMate 3 Left Ventricular Assist System Wins CARDIOSTIM-EHRA EUROPACE Innovation Award
-
St. Jude Medical Broadens Treatment Options for Patients Suffering Movement Disorders with the European Launch of New Deep Brain Stimulation System and Directional Lead
-
St. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe
-
St. Jude Medical (STJ) Announces Presentation of New FFR Tech Data
-
New Data Presented at EuroPCR 2016 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical FFR Technology and LAA Closure
-
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
-
St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology
-
New Data Showcases the Long-Term Clinical Benefits of the Nanostim Leadless Pacemaker Compared to Traditional Pacemakers
-
St. Jude Medical Announces MultiPoint Pacing IDE Study Results During Late-Breaker at Heart Rhythm 2016
-
St. Jude Medical Announces Dividend for Second Quarter of Fiscal Year 2016
-
Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients
-
Abbott (ABT) to Acquire St. Jude Medical (STJ) in ~$31B Deal
-
St. Jude Medical Reports First Quarter 2016 Results
-
St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark
-
St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology
-
St. Jude Medical (STJ) Launches Axium Neurostimulator System for DRG in U.S.
-
St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy
-
St. Jude Medical (STJ) Launches Trifecta Valve with GT in Europe
-
St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement
-
St. Jude Medical Announces First Quarter 2016 Earnings Conference Call
-
St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations
-
St. Jude Medical (STJ) Announces Positive CardioMEMS HF System-Related Independent Data
-
New Independent Data Confirms Benefits of the St. Jude Medical CardioMEMS HF System
-
St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads
-
St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker
-
St. Jude Medical to Present at the Barclays Global Healthcare Conference
-
St. Jude Medical Announces Increase in Quarterly Dividend
-
FDA Panel Provides Leadership and Guidance to Companies Seeking to Advance Leadless Pacing Technology in the U.S.
-
St. Jude Medical (STJ) Receives FDA Approval for Quadra/Quartet -Enhanced MultiPoint Pacing Technology
-
St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology
-
St. Jude Medical's (STJ) Axium Neurostimulator System Approved by U.S. FDA in DRG Stimulation
-
St. Jude Medical Announces FDA Approval of a New Treatment Therapy for Patients Suffering From Chronic Intractable Pain
-
St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan
-
St. Jude Medical Announces 2016 Annual Analyst and Investor Meeting
-
St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results
-
St. Jude Medical (STJ) Says Optisure Dual Coil Defibrillation Leads Now Classified as Class 1 Advisory
-
FDA Classifies St. Jude Medical Field Action for 447 of the Company's Optisure High Voltage Leads as a Class 1 Advisory in the U.S.
-
St. Jude Medical (STJ) Prelim. Q4 Sales Light of Expectations
-
St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results
-
St. Jude Medical Announces Fourth Quarter and Full-Year 2015 Earnings Conference Call
-
St. Jude Medical to Present at the 34th Annual J.P. Morgan Healthcare Conference
-
Long Term Data Confirms the St. Jude Medical Axium System Delivers Sustained and Superior Pain Relief for Patients with Chronic Lower Limb Pain
-
St. Jude Medical (STJ) Says Data Shows Burst is Superior to Traditional Tonic SCS in Relieving Chronic Pain
-
New Data Demonstrates Burst Stimulation from St. Jude Medical Provides Superior Pain Relief over Traditional Tonic Spinal Cord Stimulation for the Treatment of Chronic Pain
-
St. Jude Medical Announces Fourth Quarter Dividend
-
St. Jude Medical Announces CE Mark for MRI Compatibility on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients
-
St. Jude Medical Announces European Launch of the World’s First and Only Upgradeable, Non-Rechargeable, Burst-Enabled MR-Conditional SCS System
-
Watch the latest episode of BizWireTV from Business Wire
-
St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option
-
New Long-term Data Published in The Lancet Further Demonstrates Superiority of the CardioMEMS HF System over Standard of Care

